Testing effectiveness (Phase 2)UnknownNCT04247256
What this trial is testing
Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
Who this might be right for
Metastatic Colorectal Cancer
Scandion Oncology A/S 35